NEW YORK (GenomeWeb News) - Sloning Biotechnology has entered the synthetic gene-production market this month with an automated process, the company said today.
The company's technology, named Slonomics, will use a library of universal double-stranded DNA building blocks that the company will assemble with industrial robotic machines.
Additional details were not disclosed.